Cubist Systematic Strategies LLC Has $1.90 Million Stock Holdings in Mettler-Toledo International, Inc. $MTD

Key Points

• Cubist Systematic Strategies LLC reduced its holdings in Mettler-Toledo International by 76.1%, selling 5,114 shares during the first quarter.
• Mettler-Toledo International's shares recently opened at $1,304.65, with a market capitalization of $26.88 billion and a twelve-month price range between $946.69 and $1,521.01.
• Company analysts generally have a consensus rating of "Moderate Buy" for Mettler-Toledo, with price targets ranging from $1,230.00 to $1,600.00.

Cubist Systematic Strategies LLC lowered its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 76.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,607 shares of the medical instruments supplier's stock after selling 5,114 shares during the period. Cubist Systematic Strategies LLC's holdings in Mettler-Toledo International were worth $1,897,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in MTD. Mercer Global Advisors Inc. ADV raised its stake in Mettler-Toledo International by 13.2% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 480 shares of the medical instruments supplier's stock valued at $588,000 after acquiring an additional 56 shares in the last quarter. Benjamin Edwards Inc. raised its stake in Mettler-Toledo International by 8.8% during the 4th quarter. Benjamin Edwards Inc. now owns 210 shares of the medical instruments supplier's stock valued at $257,000 after acquiring an additional 17 shares in the last quarter. Captrust Financial Advisors raised its stake in Mettler-Toledo International by 11.6% during the 4th quarter. Captrust Financial Advisors now owns 656 shares of the medical instruments supplier's stock valued at $802,000 after acquiring an additional 68 shares in the last quarter. Cetera Investment Advisers raised its stake in Mettler-Toledo International by 8.7% during the 4th quarter. Cetera Investment Advisers now owns 1,075 shares of the medical instruments supplier's stock valued at $1,315,000 after acquiring an additional 86 shares in the last quarter. Finally, Deutsche Bank AG raised its stake in shares of Mettler-Toledo International by 1.4% in the 4th quarter. Deutsche Bank AG now owns 106,657 shares of the medical instruments supplier's stock worth $130,514,000 after buying an additional 1,487 shares in the last quarter. Institutional investors own 95.07% of the company's stock.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of the business's stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the transaction, the insider owned 94 shares in the company, valued at $123,012.16. The trade was a 63.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Shawn Vadala sold 300 shares of the business's stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares in the company, valued at $6,389,588.55. This trade represents a 5.56% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,827 shares of company stock worth $2,371,208 over the last 90 days. 1.94% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on MTD shares. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and dropped their price objective for the stock from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Robert W. Baird boosted their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Citigroup boosted their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a research note on Thursday, August 21st. Barclays initiated coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price objective on the stock. Finally, Evercore ISI decreased their target price on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a report on Monday, August 4th. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $1,311.11.

Mettler-Toledo International Stock Performance

Shares of MTD stock traded down $18.11 on Friday, reaching $1,264.62. 14,840 shares of the company's stock traded hands, compared to its average volume of 169,007. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,521.01. The company has a market capitalization of $26.05 billion, a P/E ratio of 32.02, a price-to-earnings-growth ratio of 3.76 and a beta of 1.37. The business's 50 day moving average price is $1,257.96 and its two-hundred day moving average price is $1,186.40.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. During the same quarter in the previous year, the company posted $9.65 earnings per share. The business's quarterly revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Research analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.